Previous 10 | Next 10 |
home / stock / bayry / bayry news
2024-03-25 13:07:32 ET Summary M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance sheets, key patent expirations, and declining revenue from Covid related products. The oncology space continues to be a hot ...
2024-03-21 12:53:07 ET More on Boundless Bio, Inc. Boundless Bio Starts $100 Million U.S. IPO Plan IPO Roundup: Boundless Bio, NeOnc Technologies and more Oncology drug developer Boundless Bio files for $100M IPO Financial information for Boundless Bio, Inc. ...
2024-03-19 08:19:47 ET More on Fusion Pharmaceuticals Fusion Pharmaceuticals' Partnerships Strengthen Long-Term Outlook Biggest stock movers today: FUSN, NCMI, crypto stocks and more AstraZeneca will buy Fusion Pharmaceuticals for ~$2B Seeking Alpha’s ...
2024-03-19 06:19:29 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said Tuesday it would seek marketing approval for its experimental menopause treatment, elinzanetant, after the drug was shown to reduce the frequency of hot flashes associated with menopause in a third late-stage trial......
2024-03-13 17:43:59 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-12 12:09:42 ET Summary Bicycle Therapeutics plc results from the phase 1/2 Duravelo-1 study, using BT8009 for the treatment of patients with metastatic urothelial carcinoma, expected in the 2nd half of 2024. Data from BT5528 [Bicycle toxin conjugate tech] and BT7480 [Bicyc...
2024-03-07 14:54:46 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-07 11:35:38 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-06 10:49:13 ET More on Bayer Bayer Q4 2023 Earnings Call Transcript Bayer Fiscal 2023 Results: Mr. Anderson, Deliver Us From Bad News Bayer: Long-Term Upside After The Dividend Cut Read the full article on Seeking Alpha For further details see...
2024-03-05 10:08:10 ET Bayer AG (BAYZF) Q4 2023 Earnings Conference Call March 05, 2024, 03:30 ET Company Participants Michael Preuss - Head, Communications, Government Relations and Corporate Brand Julio Triana - Head, Commercial Operations Region International ...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...